Advyzon Investment Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 2011872 LISLE, IL

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$520,322

+$223,637 QoQ

Shares Held

9,563

+41.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#422

of 751 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Advyzon Investment Management, LLC holds $2,492,343 across 4 Biotechnology names. EXEL ranks #3 (20.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,740	$864,309
2	HRMY	Harmony Biosciences Holdings, Inc.	20,168	$734,316
3	EXEL	Exelixis, Inc. This page	9,563	$520,322
4	ARWR	Arrowhead Pharmaceuticals, Inc.	4,581	$373,396

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$520,322	9,563	+41.3%	Shares	Other	2026-08-14
2025-12-31	$296,685	6,769	—	Shares	Other	2026-02-13
No filing history on record for this holder in this stock.